BabySeq is a clinical trial exploring how to responsibly share genetic risk information found in the DNA of healthy babies.

Illumina, which specializes in DNA sequencing, will work on samples representing 1,300 species in the San Diego Zoo Wildlife Alliance's Frozen Zoo.

Model predicts effect of mutations on sequences up to 1 million base pairs in length and is adept at tackling complex ...

DeepMind’s AlphaGenome AI model could help solve the problem of predicting how variations in noncoding DNA shape gene ...

Once disregarded as “junk DNA,” scientists now know that this molecular dark matter is crucial for determining gene activity ...

Google has announced plans to deploy AI tools to prevent the extinction of endangered species of animals by preserving their ...

As biological data volume continues to grow, sequence-based AI is poised to become the dominant discovery layer across pharma ...

It could transform our understanding of why diseases develop and the medicines needed to treat them, says researchers.

AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely ...

A study published in Nature looks at genetic determinants of persistent Epstein-Barr virus DNA and associations with chronic conditions. Prof Lawrence Young, Virologist and Emeritus Professor of ...

In his Nobel Prize acceptance speech in 1980, genomics pioneer Fred Sanger described science as “a voyage of discovery into ...

San Diego’s Illumina is the world leader in gene sequencing technology — the ability to read and record DNA. Now, the billion-dollar company is buying another in a bid to expand its portfolio in ...